Browse Category

Financial Updates News 4 December 2025 - 7 December 2025

Protara Therapeutics (TARA) Stock Plunges After $75 Million Offering: Latest Trial Data, Analyst Targets and Outlook as of December 5, 2025

Protara Therapeutics (TARA) Stock Plunges After $75 Million Offering: Latest Trial Data, Analyst Targets and Outlook as of December 5, 2025

Published: December 5, 2025 Protara Therapeutics, Inc. (NASDAQ: TARA) is ending the week in dramatic fashion. After a string of positive clinical updates for its lead cell therapy TARA‑002, the company has tapped equity markets with a $75 million public
Polyrizon (PLRZ) Stock Doubles on Naloxone Hydrogel Breakthrough and PL‑14 Manufacturing Milestone – What Investors Need to Know on December 4, 2025

Polyrizon (PLRZ) Stock Doubles on Naloxone Hydrogel Breakthrough and PL‑14 Manufacturing Milestone – What Investors Need to Know on December 4, 2025

Polyrizon Ltd. (NASDAQ: PLRZ) has exploded into the spotlight after a two‑day run that has turned an obscure micro‑cap biotech into one of the most talked‑about healthcare stocks on the Nasdaq. By early afternoon on December 4, 2025, Polyrizon shares
Platinum Price Today, December 4, 2025: Spot Platinum Slips Toward $1,650 After a Breakout Year

Platinum Price Today, December 4, 2025: Spot Platinum Slips Toward $1,650 After a Breakout Year

Spot platinum is trading around $1,650–$1,660 per troy ounce on Thursday, December 4, 2025, easing from recent highs as investors take profits ahead of a pivotal US Federal Reserve meeting. Live quotes from major bullion dealers show platinum near $1,656–$1,660/oz, roughly 1.7–2.1% lower than Wednesday’s
1 17 18 19 20 21 23
Go toTop